Head-to-head dispatch
Eden vs LIV by WellNow
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
High-disclosure compounded program — the clearest verification signals in the ranking — with a $99/mo medication price that only reads that low because the required $99/mo membership is billed separately.
$198/mo all-in month to month ($99/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $138 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) sema · $298/mo all-in month to month ($199/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $238 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) tirz · Verified August 28, 2026
Marked down on: FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Desk Score
LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide at $195/month for the average dose — medication, supplies and unlimited virtual visits included — from a named pharmacy.
$195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly sema · Verified August 29, 2026
Marked down on: The price follows the DOSE: $195/month covers the average 1 mg dose, but 1.7 mg or 2.4 mg costs $265/month, and the headline says "no hidden fees"
Eden takes this head-to-head with the higher Desk Score, 85/100 (B) against 71/100 (C) for LIV by WellNow. LIV by WellNow still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Eden
85/100
B
LIV by WellNow
71/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Eden | LIV by WellNow |
|---|---|---|
| Semaglutide | $198/mo all-in month to month ($99/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $138 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) | $195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly |
| Tirzepatide | $298/mo all-in month to month ($199/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $238 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) | Not listed on LIV by WellNow's site (checked August 29, 2026) |
| Coverage | All 50 states | 5 states (IL, IN, MI, NY, PA) |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | People who weight clinical transparency and oversight over finding the cheapest rate, and who are fine with a two-line bill (medication plus membership) that comes to $198/mo semaglutide or $298/mo tirzepatide. | Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung. |
| Desk Score | 85/100B | 71/100C |
The verdict
Desk pick — EdenEden takes this head-to-head with the higher Desk Score, 85/100 (B) against 71/100 (C) for LIV by WellNow. LIV by WellNow still holds its ground where its strengths line up with yours.
Choose Eden if…
People who weight clinical transparency and oversight over finding the cheapest rate, and who are fine with a two-line bill (medication plus membership) that comes to $198/mo semaglutide or $298/mo tirzepatide.
$198/mo all-in month to month ($99/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $138 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) sema · $298/mo all-in month to month ($199/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $238 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable) tirz · All 50 states
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Choose LIV by WellNow if…
Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.
$195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly sema · 5 states (IL, IN, MI, NY, PA)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Eden · LIV by WellNow.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Eden
- CoreAge Rx vs LIV by WellNow
- Eden vs Vytora Health
- LIV by WellNow vs Vytora Health
- Eden vs Pallas Health
- LIV by WellNow vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.